Midkine expression in colorectal tumors: Correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones

Pathology International

Volumn 57, Issue 5, 2007, Pages 260-267

  Tokuyama, Wataru ^a,d   Mikami, Tetuo ^a   Fujiwara, Mutsunori ^b   Matsui, Takashi ^c   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c Cell Signals Inc   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Colonic tumor; Ki 67; Midkine; Ulcerative colitis associated carcinoma

Indexed keywords

MIDKINE; MONOCLONAL ANTIBODY KI 67; SINGLE STRANDED DNA;

ADENOMA; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; ULCERATIVE COLITIS;

ADENOCARCINOMA; ADENOMA; BLOTTING, WESTERN; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CYTOKINES; DISEASE PROGRESSION; DNA, SINGLE-STRANDED; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; KI-67 ANTIGEN;

EID: 34247106304     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02095.x     Document Type: Article

References (41)

1. Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell 1991; 64: 271-80.
2. Aaronson SA. Growth factors and cancer. Science 1991; 254: 1146-53.
3. Pusztai L, Lewis CE, Lorenzen J, McGee JO. Growth factors: Regulation of normal and neoplastic growth. J Pathol 1993; 169: 191-201.
4. Kadomatsu K, Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett 2004; 204: 127-43.
5. Kurtz A, Schulte AM, Wellstein A. Pleiotrophin and midkine in normal development and tumor biology. Crit Rev Oncog 1995; 6: 151-77.
6. Tomomura M, Kadomatsu K, Nakamoto M et al. A retinoic acid responsive gene, MK, produces a secreted protein with heparin binding activity. Biochem Biophys Res Commun 1990; 171: 603-9.
7. Muramatsu H, Muramatsu T. Purification of recombinant midkine and examination of its biological activities: Functional comparison of new heparin binding factors. Biochem Biophys Res Commun 1991; 177: 652-8.
8. Nurcombe V, Fraser N, Herlaar E, Heath JK. MK: A pluripotential embryonic stem-cell-derived neuroregulatory factor. Development 1992; 116: 1175-83.
9. Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T. Midkine, a retinoic acid-inducible growth/differentiation factor: Immunochemical evidence for the function and distribution. Dev Biol 1993; 159: 392-402.
10. Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H, Muramatsu T. Midkine induces the transformation of NIH3T3 cells. Br J Cancer 1997; 75: 354-9.
11. Takei Y, Kadomatsu K, Matsuo S et al. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells. Cancer Res 2001; 61: 8486-91.
12. Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
13. Benhattar J, Saraga E. Molecular genetics of dysplasia in ulcerative colitis. Eur J Cancer 1995; 31A: 1171-3.
14. Wong NA, Harrison DJ. Colorectal neoplasia in ulcerative colitis-recent advances. Histopathology 2001; 39: 221-34.
15. Mikami T, Yoshida T, Shiraishi H, Tokuyama W, Motoori T, Okayasu I. Bottom-up cell proliferation with cyclin A and p27 expression in ulcerative colitis-associated dysplasia. Pathol Int 2006; 56: 10-16.
16. Yoshida T, Mikami T, Mitomi H, Okayasu I. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: Full-length gene sequencing in microdissected single crypts. J Pathol 2003; 199: 166-75.
17. Walsh S, Murphy M, Silverman M et al. p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis. Am J Pathol 1999; 155: 1511-8.
18. Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
19. Jass JR, Sobin LH, eds. Histological Typing of Intestinal Tumours, 2nd edn. Berlin: Springer-Verlag, 1989.
20. Murasugi A, Tohma-Aiba Y. Production of native recombinant human midkine in the yeast, Pichia pastoris. Protein Expr Purif 2003; 27: 244-52.
21. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55: 237-41.
22. Aridome K, Tsutsui J, Takao S et al. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 1995; 86: 655-61.
23. Ye C, Qi M, Fan QW et al. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br J Cancer 1999; 79: 179-84.
24. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res 1996; 56: 2515-18.
25. Mishima K, Asai A, Kadomatsu K et al. Increased expression of midkine during the progression of human astrocytomas. Neurosci Lett 1997; 233: 29-32.
26. Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 1997; 57: 1814-19.
27. Paul S, Mitsumoto T, Asano Y, Kato S, Kato M, Shinozawa T. Detection of truncated midkine in Wilms' tumor by a monoclonal antibody against human recombinant truncated midkine. Cancer Lett 2001; 163: 245-51.
28. Aridome K, Takao S, Kaname T et al. Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. Br J Cancer 1998; 78: 472-7.
29. Miyashiro I, Kaname T, Nakayama T et al. Expression of truncated midkine in human colorectal cancers. Cancer Lett 1996; 106: 287-91.
30. Paul S, Mitsumoto T, Yamamoto I, Shinozawa T. Molecular cloning, expression and purification of truncated midkine and its growth stimulatory activity on Wilms' tumor (G401) cells. Cancer Lett 2001; 163: 239-44.
31. Nobata S, Shinozawa T, Sakanishi A. Truncated midkine induces transformation of cultured cells and short latency of tumorigenesis in nude mice. Cancer Lett 2005; 219: 83-9.
32. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY. Pleiotrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 2002; 397: 162-71.
33. Li YS, Milner PG, Chauhan AK et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 1990; 250: 1690-94.
34. Garver RI Jr, Chan CS, Milner PG. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol 1993; 9: 463-6.
35. Yamakawa T, Kurosawa N, Kadomatsu K et al. Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers. Cancer Lett 1999; 135: 91-6.
36. Mikami T, Yoshida T, Akino F, Motoori T, Yajima M, Okayasu I. Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2. Am J Clin Pathol 2003; 119: 723-30.
37. Yoshida T, Matsumoto N, Mikami T, Okayasu I. Upregulation of p16 (INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours. Br J Cancer 2004; 91: 1081-8.
38. Noffsinger AE, Miller MA, Cusi MV, Fenoglio-Preiser CM. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer 1996; 78: 2307-12.
39. Wong NA, Mayer NJ, MacKell S, Gilmour HM, Harrison DJ. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 2000; 37: 108-14.
40. Ohuchida T, Okamoto K, Akahane K et al. Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity. Cancer 2004; 100: 2430-36.
41. Owada K, Sanjyo N, Kobayashi T et al. Midkine inhibits apoptosis via extracellular signal regulated kinase (ERK) activation in PC12 cells. J Med Dent Sci 1999; 46: 45-51.